Group 6 Copy 253
0
    Please wait...

    About This Project

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

    One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

    Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

    Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

    Backer Badge Funded

    A medicine project funded by 19 people